Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations.

MLA

Gintant, Gary, et al. “Repolarization Studies Using Human Stem Cell-Derived Cardiomyocytes: Validation Studies and Best Practice Recommendations.” Regulatory Toxicology and Pharmacology : RTP, vol. 117, Nov. 2020, p. 104756. EBSCOhost, https://doi.org/10.1016/j.yrtph.2020.104756.

APA

Gintant, G., Kaushik, E. P., Feaster, T., Stoelzle-Feix, S., Kanda, Y., Osada, T., Smith, G., Czysz, K., Kettenhofen, R., Lu, H. R., Cai, B., Shi, H., Herron, T. J., Dang, Q., Burton, F., Pang, L., Traebert, M., Abassi, Y., Pierson, J. B., & Blinova, K. (2020). Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations. Regulatory Toxicology and Pharmacology : RTP, 117, 104756. https://doi.org/10.1016/j.yrtph.2020.104756

Chicago

Gintant, Gary, Emily Pfeiffer Kaushik, Tromondae Feaster, Sonja Stoelzle-Feix, Yasunari Kanda, Tomoharu Osada, Godfrey Smith, et al. 2020. “Repolarization Studies Using Human Stem Cell-Derived Cardiomyocytes: Validation Studies and Best Practice Recommendations.” Regulatory Toxicology and Pharmacology : RTP 117 (November): 104756. doi:10.1016/j.yrtph.2020.104756.